Opaleye Management Inc. - LUMOS PHARMA INC ownership

LUMOS PHARMA INC's ticker is LUMO and the CUSIP is 55028X109. A total of 43 filers reported holding LUMOS PHARMA INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Opaleye Management Inc. ownership history of LUMOS PHARMA INC
ValueSharesWeighting
Q3 2022$412,000
+148.2%
46,576
+116.4%
0.17%
+126.7%
Q2 2022$166,000
-95.7%
21,520
-94.4%
0.08%
-88.2%
Q2 2021$3,820,000
-13.4%
382,000
+1.4%
0.63%
-2.2%
Q1 2021$4,410,000
-56.1%
376,900
+34.0%
0.65%
-50.6%
Q4 2020$10,045,000
+201.7%
281,287
+16.8%
1.31%
+101.5%
Q3 2020$3,329,000240,8920.65%
Other shareholders
LUMOS PHARMA INC shareholders Q1 2021
NameSharesValueWeighting ↓
Minerva Advisors LLC 34,015$321,0000.21%
Lion Point Capital, LP 51,205$481,0000.11%
Wealth Advisors of Iowa, LLC 11,699$110,0000.06%
NEA Management Company, LLC 167,608$1,575,0000.04%
Paladin Advisory Group, LLC 4,382$40,0000.03%
Marquette Asset Management, LLC 13,315$125,0000.03%
Blackstone Inc. 468,145$4,401,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 47,643$450,0000.01%
Jefferies Group LLC 120,651$1,134,1190.01%
Renaissance Technologies 271,712$2,554,0000.00%
View complete list of LUMOS PHARMA INC shareholders